PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)

IDX:DGNS Cash Flow Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	3,346	2,937	747.44	-13,656	12,665	64,304
Depreciation & Amortization	11,011	11,011	14,612	14,634	13,310	7,562
Other Amortization	308.69	308.69	271.39	-	-	-
Other Operating Activities	-2,313	-3,598	11,668	12,205	-31,931	-12,990
Operating Cash Flow	12,353	10,658	27,299	13,184	-5,956	58,875
Operating Cash Flow Growth	-35.93%	-60.96%	107.07%	-	-	124.47%
Capital Expenditures	-6,687	-8,073	-43,394	-38,324	-34,096	-67,841
Sale of Property, Plant & Equipment	102.72	110.72	117.12	649.65	-	-
Sale (Purchase) of Intangibles	-556.26	-625.82	-904.18	-208	-756.8	-
Investment in Securities	-	-	-	-4,506	-8,051	-6,507
Other Investing Activities	-	-	-	-	25,354	-1,219
Investing Cash Flow	-7,141	-8,588	-44,181	-42,389	-17,550	-75,568
Long-Term Debt Issued	-	5,000	15,000	38,978	11,606	-
Long-Term Debt Repaid	-	-2,373	-2,744	-23,728	-4,749	-4,900
Net Debt Issued (Repaid)	-3,693	2,627	12,256	15,250	6,857	-4,900
Issuance of Common Stock	-	-	-	-	-	49,478
Common Dividends Paid	-	-	-	-	-	-6,000
Other Financing Activities	-788.01	-431.03	-1,409	-3,810	-	6,296
Financing Cash Flow	-4,481	2,196	10,846	11,439	6,857	44,874
Miscellaneous Cash Flow Adjustments	-0	-	-	-	-60	-
Net Cash Flow	731.06	4,266	-6,036	-17,766	-16,709	28,182
Free Cash Flow	5,665	2,585	-16,095	-25,141	-40,052	-8,966
Free Cash Flow Margin	3.31%	1.55%	-9.87%	-17.26%	-20.77%	-2.97%
Free Cash Flow Per Share	4.53	2.07	-12.88	-20.11	-32.04	-7.23
Cash Interest Paid	3,739	3,739	2,614	475.24	772	-
Cash Income Tax Paid	-	-	-	10.08	20,082	16,185
Levered Free Cash Flow	6,481	2,308	-20,631	-17,955	-13,691	-29,353
Unlevered Free Cash Flow	6,965	2,793	-20,080	-17,658	-13,298	-29,146

Source: S&P Global Market Intelligence. Standard template. Financial Sources.